Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 755.03

+1.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (14)	12/30/1996 2:40:00 PM
From: cl	of 3560

You are right. I totally forgot about the 10Q. I always have peace of mind on this stock since I believe in their research capabilities and I have the assumptions the stock moves with new discovery and new interests from corporate partners. Now, the 10Q doesn't look that good particulary there seems to be little confidence in the success of the trial. With the additional complication of Rilutek, is a new headache. Sell off? maybe, it probably would be around 14... but I bought the thing without weighing a lot on the NT-3/BDNF/CNTF ordeal, but purely considering their research potential. So I would probably add more share if it really goes low. --Chuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next